Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
Similar Companies1000
CorEvitas
CorEvitas provides real-world evidence to help biopharmaceutical companies bring safe and effective treatments to market.
Sector
Subsector
Keywords
Location
total rounds
Tempus
Tempus is an AI company improving cancer treatment through molecular data.
Sector
Subsector
Location
total rounds
total raised
count Of Investments
Global Kinetics Corporation
Global Kinetics Corporation commercialises technology that records and reports movement symptoms of neurological disease.
Sector
Subsector
Keywords
Location
total rounds
total raised
Molecular Health
Molecular Health provides software solutions for evidence-based healthcare decision support and drug development.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds3
Number of Funding Rounds
Money Raised
Their latest funding was raised on 21.12.2011. Their latest round Debt Financing
Avalon Ventures
Avalon Ventures is a venture capital firm focused on information technology and life sciences.
Sector
Subsector
Location
count Of Investments
count Of Exists
Ambit Biosciences
Ambit Biosciences develops small molecule kinase inhibitors for cancer and inflammatory disease treatments.
Sector
Subsector
Location
total rounds
total raised
count Of Investments
Co-Investors
Investors3
Number of lead investors
Number of investors
Avalon Ventures
Avalon Ventures is a venture capital firm focused on information technology and life sciences.
Sector
Subsector
Location
count Of Investments
count Of Exists
Torrey Pines Investment
San Diego venture capital firm investing in life science, biotech, and pharma.
Sector
Subsector
Location
count Of Investments
count Of Exists
Ambit Biosciences
Ambit Biosciences develops small molecule kinase inhibitors for cancer and inflammatory disease treatments.
Sector
Subsector
Location
total rounds
total raised
count Of Investments
People
Founders2
Ben Vollrath
Ben is a seasoned life sciences executive and entrepreneur with over 15 years of experience in pharmaceutical and biotech companies. Ben also has an extensive background in developing biotech startups from inception to exit. Prior to Amprion, Ben served as CEO of Xetrios Therapeutics, an emerging biotech company focused on the development of novel therapeutics for immunological disorders and cancer. Xetrios was acquired by Kolltan Pharmaceuticals in 2014. Ben spent over 4 years as Entrepreneur in Residence at Avalon Ventures, a San Diego-based VC firm focused on developing early-stage life science companies. During his tenure with Avalon Ventures, Ben was a co-founder and senior member of the management teams of several biotech companies, including Afraxis (focused on CNS therapeutics, subsequently sold to Genentech for $187M), Carolus Therapeutics (focused on therapeutics for inflammatory diseases) and Otonomy (Nasdaq: OTIC, focused on therapeutics for diseases of the inner and middle ear). Prior to Avalon, Ben served as a scientist at Renovis, a San Francisco-based CNS drug discovery company and Merck. Ben also brings a broad experience in managing virtual and semi-virtual research programs. He is named inventor on over 40 patents or patent applications.
current job
organization founded
Ben Vollrath
Jay Lichter
Jay Lichter is the Managing Director of Avalon Ventures and he was also the CEO of Sitari Pharmaceuticals. Dr. Lichter received a doctorate and bachelor’s degree in biochemistry from the University of Illinois. He also completed post-doctoral fellowships at Yale University and Du Pont Merck Pharmaceutical Company.
current job
Jay Lichter
